0143-9144-02 · Liraglutide Injection · Hikma Pharmaceuticals USA, Inc.
What is the status for 0143-9144-02 · Liraglutide Injection · Hikma Pharmaceuticals USA, Inc.?
For 0143-9144-02, generic name is Liraglutide Injection; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Available; initial posting date is 07/18/2023, recorded from its source on 2026-11-04.
"initial_posting_date": "07/18/2023", "package_ndc": "0143-9144-02", "generic_name": "Liraglutide Injection", "contact_info": "800-631-2174", "availability": "Available"
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 0143-9144-02 verified
- Generic name
- Liraglutide Injection verified
- Manufacturer
- Hikma Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Available verified
- Initial posting date
- 07/18/2023 verified
- Last update date
- 10/14/2026 verified
- Days in shortage
- 1205 our reading
- Dosage form
- Injection verified
- Therapeutic category
- Endocrinology/Metabolism verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Dosage form and Therapeutic category
"update_date": "10/14/2026", "therapeutic_category": [ "Endocrinology/Metabolism" ], "dosage_form": "Injection", "presentation": "Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000